StepStone Group LP
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 13, 2025), StepStone Group LP reported 14 stock positions worth $114.4 million. Its top holding was Moneylion (ML) at 46.8% of the portfolio, followed by Uipath Class A (PATH, 14.3%) and Entrada Therapeutics (TRDA, 11.5%). Compared with Q3 2024, it opened 4 new positions, sold out of 4 and reduced 1. The biggest buy was a new position in Onkure Therapeutics Class A (OKUR) and the biggest sale an exit from Dun & Bradstreet (DNB).
- Most Recent 13F
- Q2 2026
- Location
- La Jolla, CA
- CIK
- 0001502287
- Portfolio Value
- $114.4M (Q4 2024)
- SEC Filing
- 0000950123-25-001948 ↗ filed Feb 13, 2025
Holdings Value
Holdings 14 stocks · $114.4M
| ML Moneylion Inc. | 46.85% | 622,931 | $53.6M | No change |
| PATH Uipath Inc. Class A | 14.30% | 1,286,527 | $16.4M | No change |
| TRDA Entrada Therapeutics Inc. | 11.51% | 761,277 | $13.2M | No change |
| DKNG Draftkings Inc. Class A | 10.47% | 321,804 | $12.0M | No change |
| OKUR Onkure Therapeutics Inc. Class A | 3.70% | 491,938 | $4.2M | New |
| NEUE Neuehealth Inc. | 3.41% | 525,247 | $3.9M | Reduce -0.4% |
| PHAT Phathom Pharmaceuticals Inc. | 3.00% | 422,085 | $3.4M | No change |
| COIN Coinbase Global Inc. Class A | 2.88% | 13,281 | $3.3M | New |
| HLVX Hillevax Inc. | 1.50% | 826,569 | $1.7M | No change |
| SENTINELONE INC | 0.69% | 35,326 | $784K | New |
| VCSA Vacasa Inc. Class A | 0.63% | 147,261 | $722K | No change |
| TNYA Tenaya Therapeutics Inc. | 0.58% | 462,163 | $661K | No change |
| GROV Grove Collaborative Holdings | 0.46% | 380,383 | $529K | No change |
| METC Ramaco Resources Inc. Class A | 0.03% | 3,787 | $39K | New |
Portfolio Sells Q3 2024 → Q4 2024
Portfolio Buys Q3 2024 → Q4 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 22 | $2.2B | SPCX, STUB, CBRS, XNDU, TMS |
| Q1 2026 | 17 | $207.2M | KRMN, STUB, XNDU, OKUR, PATH |
| Q4 2025 | 22 | $184.1M | STUB, KDK, PATH, KRMN, TRDA |
| Q3 2025 | 15 | $201.5M | STUB, KRMN, PATH, KDK, DKNG |
| Q2 2025 | 14 | $50.4M | PATH, DKNG, RBRK, TRDA, PHAT |
| Q1 2025 | 16 | $97.4M | ML, PATH, DKNG, TRDA, NEUE |
| Q4 2024 | 14 | $114.4M | ML, PATH, TRDA, DKNG, OKUR |
| Q3 2024 | 14 | $274.1M | DNB, ML, RBLX, RKLB, PATH |
| Q2 2024 | 16 | $493.1M | DNB, WKME, ML, RKLB, RBLX |
| Q1 2024 | 21 | $471.6M | DNB, WKME, ML, RKLB, PATH |